Europe
DBV announced official restructuring plan for keeping the company afloat.
The recalibration will also have workforce implications, including an overall workforce reduction of approximately 20% during Q1, 2021.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business.
SARS-CoV-2 has mutated into several strains. Most of them are not particularly different than the primary strains, but two, B.1.1.7, which was first observed in the U.K., and now 501.V2, which originated in South Africa, have virologists watching closely.
2021 is off to a hopeful start for some companies, executives and scientists, while others are forced to fold programs and recalibrate.
With COVID-19 still running rampant across the globe, Moderna announced it will rapidly expand its vaccine manufacturing operations in order to meet demand in the countries where the medication has received emergency authorization.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
Dr. Lynn Seely bows out as Myovant pivots to commercialize new drug.
The U.K authorized AstraZeneca’s COVID-19 vaccine on Wednesday, but it could be April at the earliest before the drug will likely be administered in the United States, Operation Warp Speed’s chief said.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
PRESS RELEASES